Chemical validation of phosphodiesterase C as a chemotherapeutic target in Trypanosoma cruzi, the etiological agent of Chagas' disease

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 9, 2010, Pages 3738-3745

  King Keller, Sharon ^a   Li, Minyong ^b   Smith, Alyssa ^a   Zheng, Shilong ^b   Kaur, Gurpreet ^b   Yang, Xiaochuan ^b   Wang, Binghe ^b   Docampo, Roberto ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; PHOSPHODIESTERASE; PHOSPHODIESTERASE C; PHOSPHODIESTERASE INHIBITOR; UNCLASSIFIED DRUG;

AMASTIGOTE; ARTICLE; CHAGAS DISEASE; IN VITRO STUDY; PRIORITY JOURNAL; SCREENING; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; ENZYME INHIBITORS; MOLECULAR STRUCTURE; PHOSPHORIC DIESTER HYDROLASES; PROTOZOAN PROTEINS; TRYPANOSOMA CRUZI;

EID: 77956131207     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00313-10     Document Type: Article

References (37)

1. Agarwal, N., G. Lamichhane, R. Gupta, S. Nolan, and W. R. Bishai. 2009. Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase. Nature 460:98-102.
2. Alonso, G. D., A. C. Schoijet, H. N. Torres, and M. M. Flawia. 2006. TcPDE4, a novel membrane-associated cAMP-specific phosphodiesterase from Trypanosoma cruzi. Mol. Biochem. Parasitol. 145:40-49.
3. Breadth Technology. 2007. IDEA. Breadth Technology, Taipei, Taiwan.
4. Card, G. L., B. P. England, Y. Suzuki, D. Fong, B. Powell, B. Lee, C. Luu, M. Tabrizizad, S. Gillette, P. N. Ibrahim, D. R. Artis, G. Bollag, M. V. Milburn, S. H. Kim, J. Schlessinger, and K. Y. Zhang. 2004. Structural basis for the activity of drugs that inhibit phosphodiesterases. Structure 12:2233-2247.
5. Case, D. A., T. E. Cheatham III, T. Darden, H. Gohlke, R. Luo, K. M. Merz, Jr., A. Onufriev, C. Simmerling, B. Wang, and R. J. Woods. 2005. The Amber biomolecular simulation programs. J. Comput. Chem. 26:1668-1688.
6. Docampo, R., S. N. Moreno, and A. E. Vercesi. 1993. Effect of thapsigargin on calcium homeostasis in Trypanosoma cruzi trypomastigotes and epimastigotes. Mol. Biochem. Parasitol. 59:305-313.
7. Eldridge, M. D., C. W. Murray, T. R. Auton, G. V. Paolini, and R. P. Mee. 1997. Empirical scoring functions. I. The development of a fast empirical function to estimate the binding affinity of ligands in receptor complexes. J. Comput. Aided Mol. Des. 11:425-445.
8. Ewing, T. J., S. Makino, A. G. Skillman, and I. D. Kuntz. 2001. DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J. Comput. Aided Mol. Des. 15:411-428.
9. Feher, M. 2006. Consensus scoring for protein-ligand interactions. Drug Discov. Today 11:421-428.
10. Ginalski, K. 2006. Comparative modeling for protein structure prediction. Curr. Opin. Struct. Biol. 16:172-177.
11. Goldstein, I., T. F. Lue, H. Padma-Nathan, R. C. Rosen, W. D. Steers, and P. A. Wicker. 1998. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N. Engl. J. Med. 338:1397-1404.
12. Huang, H., L. M. Weiss, F. Nagajyothi, H. B. Tanowitz, M. Wittner, G. A. Orr, and Y. Bao. 2006. Molecular cloning and characterization of the protein kinase A regulatory subunit of Trypanosoma cruzi. Mol. Biochem. Parasitol. 149:242-245.
13. Jakalian, A., B. L. Bush, D. B. Jack, and C. I. Bayly. 2000. Fast, efficient generation of high quality atomic charges. AM1-BCC model: I. Method. J. Comput. Chem. 21:132-146.
14. Jakalian, A., D. B. Jack, and C. I. Bayly. 2002. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J. Comput. Chem. 23:1623-1641.
15. Kunz, S., M. Oberholzer, and T. Seebeck. 2005. A FYVE-containing unusual cyclic nucleotide phosphodiesterase from Trypanosoma cruzi. FEBS J. 272: 6412-6422.
16. Laxman, S., and J. A. Beavo. 2007. Cyclic nucleotide signaling mechanisms in trypanosomes: possible targets for therapeutic agents. Mol. Interv. 7:203-215.
17. Li, M., H. Fang, L. Du, L. Xia, and B. Wang. 2008. Computational studies of the binding site of alpha1A-adrenoceptor antagonists. J. Mol. Model. 14: 957-966.
18. Li, M., Y. J. Huang, P. C. Tai, and B. Wang. 2008. Discovery of the first SecA inhibitors using structure-based virtual screening. Biochem. Biophys. Res. Commun. 368:839-845.
19. Li, M., N. Ni, H. T. Chou, C. D. Lu, P. C. Tai, and B. Wang. 2008. Structure-based discovery and experimental verification of novel AI-2 quorum sensing inhibitors against Vibrio harveyi. Chem. Med. Chem. 3:1242-1249.
20. Li, M., and B. Wang. 2007. Homology modeling and examination of the effect of the D92E mutation on the H5N1 nonstructural protein NS1 effector domain. J. Mol. Model. 13:1237-1244.
21. Ling, Y., G. Sahota, S. Odeh, J. M. Chan, F. G. Araujo, S. N. Moreno, and E. Oldfield. 2005. Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations. J. Med. Chem. 48:3130-3140.
22. McGann, M. R., H. R. Almond, A. Nicholls, J. A. Grant, and F. K. Brown. 2003. Gaussian docking functions. Biopolymers 68:76-90.
23. Moustakas, D. T., P. T. Lang, S. Pegg, E. Pettersen, I. D. Kuntz, N. Brooijmans, and R. C. Rizzo. 2006. Development and validation of a modular, extensible docking program: DOCK 5. J. Comput. Aided Mol. Des. 20:601-619.
24. Muegge, I. 2003. Selection criteria for drug-like compounds. Med. Res. Rev. 23:302-321.
25. Murray, C. W., T. R. Auton, and M. D. Eldridge. 1998. Empirical scoring functions. II. The testing of an empirical scoring function for the prediction of ligand-receptor binding affinities and the use of Bayesian regression to improve the quality of the model. J. Comput. Aided Mol. Des. 12:503-519.
26. Nikawa, J., P. Sass, and M. Wigler. 1987. Cloning and characterization of the low-affinity cyclic AMP phosphodiesterase gene of Saccharomyces cerevisiae. Mol. Cell. Biol. 7:3629-3636.
27. OpenEye Scientific Software. 2007. FRED. Fast rigid exhaustive docking. OpenEye Scientific Software, Santa Fe, NM.
28. Rohloff, P., A. Montalvetti, and R. Docampo. 2004. Acidocalcisomes and the contractile vacuole complex are involved in osmoregulation in Trypanosoma cruzi. J. Biol. Chem. 279:52270-52281.
29. Rohloff, P., C. O. Rodrigues, and R. Docampo. 2003. Regulatory volume decrease in Trypanosoma cruzi involves amino acid efflux and changes in intracellular calcium. Mol. Biochem. Parasitol. 126:219-230.
30. Seebeck, T., R. Schaub, and A. Johner. 2004. cAMP signalling in the kinetoplastid protozoa. Curr. Mol. Med. 4:585-599.
31. Stahl, M., and M. Rarey. 2001. Detailed analysis of scoring functions for virtual screening. J. Med. Chem. 44:1035-1042.
32. Thompson, W. J., and M. M. Appleman. 1971. Cyclic nucleotide phosphodiesterase and cyclic AMP. Ann. N. Y. Acad. Sci. 185:36-41.
33. Tsai, K. C., S. H. Wang, N. W. Hsiao, M. Li, and B. Wang. 2008. The effect of different electrostatic potentials on docking accuracy: a case study using DOCK5.4. Bioorg. Med. Chem. Lett. 18:3509-3512.
34. Urbina, J. A., and R. Docampo. 2003. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol. 19:495-501.
35. Verkhivker, G. M., D. Bouzida, D. K. Gehlaar, P. A. Rejto, S. Arthurs, A. B. Colson, S. T. Freer, V. Larson, B. A. Luty, T. Marrone, and P. W. Rose. 2000. Deciphering common failures in molecular docking of ligand-protein complexes. J. Comput. Aided Mol. Des. 14:731-751.
36. Yan, W., and S. N. Moreno. 1998. A method to assess invasion and intracellular replication of Trypanosoma cruzi based on differential uracil incorporation. J. Immunol. Methods 220:123-128.
37. Zheng, S., G. Kaur, H. Wang, M. Li, M. Macnaughtan, X. Yang, S. Reid, J. Prestegard, B. Wang, and H. Ke. 2008. Design, synthesis, and structureactivity relationship, molecular modeling, and NMR studies of a series of phenyl alkyl ketones as highly potent and selective phosphodiesterase-4 inhibitors. J. Med. Chem. 51:7673-7688.